Skip to Main Content
TRC_PL_NEW
Menu
    • Products
      • CriticalPoint
      • Hospital Pharmacist's Letter
      • Hospital Pharmacy Technician's Letter
      • Learning Management Portal
      • NatMed Advisor
      • NatMed Pro
      • NetCE All Access
      • Pharmacist's Letter
      • Pharmacist's Letter Canada
      • Pharmacy Technician's Letter
      • Pharmacy Technician's Letter Canada
      • Prescriber Insights
      • RxAdvanced
      • RxSelect

    Subscribe Login
  • Home
  • Letter
    • Current Issue
    • Past Issues
    • Suggest a Topic
  • Browse
    • Subject
    • Featured Charts & Graphics
    • Gender-Related Care
    • Diabetes Resources
    • Immunization Resources
    • Natural Medicines Resources
    • Student Resources
    • Faculty Resources
    • Journal Club
    • All Charts & Graphics
  • Podcasts
  • Charts & Graphics
    • Featured Charts & Graphics
    • Antidepressants
    • Contraceptives
    • Diabetes Drugs
    • Do Not Crush List
    • First Time Generics
    • New Drugs
    • All Charts & Graphics >
  • CE/CME & Training
    • CE Organizer
    • Available Courses
    • My Completions
    • Live Webinars
  • Help
    • User Support
    • Contact Us

Upgrade Your Browser

We no longer support this version of your browser. We recommend that you upgrade to the latest version of Internet Explorer, Firefox, Chrome or Safari to improve your security and experience using this website.

Return to the course you were viewing

New Podcast CE Alert: "Medications for Opioid Use Disorder" is now available! Listen for FREE now. Subscribers can earn CE credits just for listening and passing a short quiz.
Become a smarter pharmacist in minutes! More CE, more resources, more value. Choose your Pharmacist's Letter membership and elevate your pharmacy practice today. Subscribe Now
  1. Home
  2. Browse
  3. Interactions
  4. Women's Health
  5. Raloxifene

Raloxifene

  • Bone & Joint (73)
  • Cardiology (296)
  • Dermatology (61)
  • Diabetes & Endocrinology (44)
  • Gastroenterology (86)
  • Hematology & Oncology (9)
  • Infectious Diseases (254)
  • Men's Health (6)
  • Natural Medicines / Supplements / Food Interactions (152)
  • Neurology (154)
  • Nutrition & Obesity (13)
  • Psychiatry (164)
  • Resources (42)
  • Respiratory & Allergy (30)
  • Transplant Meds (16)
  • Women's Health (53)
    • Oral Contraceptives (46)
    • Raloxifene (8)
1 - 8 of 8 Results
Sort Results:
  • Title: Ascending (A-Z)
  • Date: Newest First
  • Date: Oldest First
FAQ: Meds to Prevent Breast Cancer: FAQs November 2019
Article: Watch for Some Risky Drug-Supplement Combinations May 2016
Commentary: New Drug: Osphena (Ospemifene) March 2014
PL Voices: Drug Therapy for Primary Prevention of Breast Cancer September 2013
Commentary: Olmesartan and Severe Intestinal Problems September 2013
Other: Breast Cancer Risk Calculator September 2013
Article: a stronger push to offer drug therapy for primary prevention of breast cancer in higher-risk women September 2013
Article: Osphena (os-FEE-nah, ospemifene) for women with pain during intercourse due to menopause June 2013
  • 1
  • About Us
  • Our Mission
  • Our Team
  • Testimonials
  • Careers
  • Newsroom
  • Products
  • Pharmacist Solutions
  • Prescriber Solutions
  • Hospital Solutions
  • Retail Solutions
  • Group Practice Solutions
  • Support & Policies
  • Contact Us
  • Access Agreement
  • Privacy Policy

The contents of this website are not intended to be a substitute for professional medical advice, diagnosis, or treatment. See additional information.

© Therapeutic Research Center. All Rights Reserved